conclusions in our study, portal venous thrombosis was detected in the patient who died during the acute period only. a study including large numbers of budd-chiari-syndrome patients with behcet’s disease and portal venous thrombosis would be helpful to determine the prognostic significance of portal venous thrombosis in budd-chiari-syndrome patients with behcet’s disease. in addition, patients...

Schultheiss et al. [3]. The article by Lang et al. [4] points out the interdisciplinary approach that is required to select an optimal individual therapy for a given patient based on clinical presentation, underlying diseases, extension of thrombosis, and the patient’s comorbidities. A particular focus is therefore put on the surgical therapeutic options. A specific clinical challenge is a PVT ...

 Background & Aims. It is unclear whether portal vein thrombosis (PVT) unrelated to malignancy is associated with reduced survival or it is an epiphenomenon of advanced cirrhosis. The objective of this study was to assess clinical outcome in cirrhotic patients with PVT not associated with malignancy and determine its prevalence. MATERIAL AND METHODS Retrospective search in one center from Jun...

OBJECTIVE The objective of this study was to determine the sequential CT findings of controlled hepatocellular carcinoma (HCC) with main portal vein (MPV) thrombosis with the use of transcatheter arterial chemoembolization and additional intra-arterial cisplatin infusion. MATERIALS AND METHODS From January 2004 to September 2006, 138 patients with HCC invading MPV were referred to the angiogr...

AIM To evaluate the effect of portal vein thrombosis and arterioportal shunts on local tumor response in advanced cases of unresectable hepatocellular carcinoma treated by transarterial chemoembolization. METHODS A retrospective study included 39 patients (mean age: 66.4 years, range: 45-79 years, SD: 7) with unresectable hepatocellular carcinoma (HCC) who were treated with repetitive transar...

OBJECTIVE To determine the prevalence and associations of the impaired visibility of the hepatic veins (HV) on the multi-detector row computed tomography (MDCT) in cirrhotic patients. MATERIALS AND METHODS Eighty-seven consecutive cirrhotic patients undergoing triphasic liver MDCT were enrolled. The patency of the HV and the direction of the blood flow in the main portal vein, inhomogeneity o...

PURPOSE Intraarterial delivery of yttrium-90 ((90)Y)-bound microspheres (ie, radioembolization) is a promising treatment for hepatocellular carcinoma (HCC). An early concern was the "embolic" nature of the microspheres, and their potential to reduce hepatic arterial blood flow in patients with compromised portal blood flow secondary to portal vein thrombosis/occlusion (PVT). In this situation, ...

Portal vein thrombosis (PVT) is a rather uncommon disease, although the growing use of non-invasive diagnostic techniques has increased the frequency with which it is diagnosed. PVT can occur in patients with malignancies, myeloproliferative disorders (MPD) and liver cirrhosis, but several other conditions may also act as predisposing factors [1]. In Internal and Emergency Medicine, Fimognari a...

Rationale: Herein, we present a case of seemingly unprovoked portal vein thrombosis (PVT) occurring in the context of an acute cytomegalovirus (CMV) infection and prolonged debilitating fatigue. Patient concerns: A 46-year-old male airline pilot presented with a 2 week history of abdominal pain, nausea, vomiting, watery diarrhea, and daily recurrent fevers. This was in the context of progressiv...

Liver transplantation (LT) is a serious hemostatic challenge in patients with portal vein thrombosis (PVT). Advances in monitoring systems have improved surgery in this setting. We report the successful application of a point-of-care (POC) rotational viscoelastic thromboelastometry-guided (TEM) testing system (ROTEM) which allowed management of coagulation during LT in a 64-year-old cirrhotic p...